Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMALIZUMAB Cause Cardiac failure congestive? 82 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Cardiac failure congestive have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.1% of all adverse event reports for OMALIZUMAB.

82
Reports of Cardiac failure congestive with OMALIZUMAB
0.1%
of all OMALIZUMAB reports
9
Deaths
42
Hospitalizations

How Dangerous Is Cardiac failure congestive From OMALIZUMAB?

Of the 82 reports, 9 (11.0%) resulted in death, 42 (51.2%) required hospitalization, and 3 (3.7%) were considered life-threatening.

Is Cardiac failure congestive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 82 reports have been filed with the FAERS database.

What Other Side Effects Does OMALIZUMAB Cause?

No adverse event (9,736) Asthma (9,354) Urticaria (9,231) Off label use (9,199) Dyspnoea (8,323) Drug ineffective (6,747) Cough (5,926) Pruritus (5,224) Fatigue (5,053) Malaise (4,820)

What Other Drugs Cause Cardiac failure congestive?

ROSIGLITAZONE (15,085) METFORMIN\ROSIGLITAZONE (1,408) LENALIDOMIDE (1,373) AMBRISENTAN (1,359) SACUBITRIL\VALSARTAN (1,355) APIXABAN (1,144) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (1,129) AVANDIA (1,102) ADALIMUMAB (990) MACITENTAN (979)

Which OMALIZUMAB Alternatives Have Lower Cardiac failure congestive Risk?

OMALIZUMAB vs OMAVELOXOLONE OMALIZUMAB vs OMBITASVIR OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS

Related Pages

OMALIZUMAB Full Profile All Cardiac failure congestive Reports All Drugs Causing Cardiac failure congestive OMALIZUMAB Demographics